CureFit raises $110 Mn funding from Temasek Unilever and Ascent

β“˜ Featured image details: CureFit co-founders: Mukesh Bansal (L) and Ankit Nagori (R); Credits: Forbes


Healthcare and wellness startup Curefit today raised INR 832 crore (around $110 million) in its second Series D funding round led by Singapore’s Temasek, with participation from Unilever Venture Holdings and Ascent Capital. The following round came after several quarters of negotiations of CureFit with Softbank Vision Fund which did not go through.

Cutting-edge solutions to help businesses streamline their operations and increase efficiency.
β“˜ Advertisement

The latest funding deal has valued the company around INR 4,300 crores (around $570 million). CureFit last raised $120 million in June 2019 from a number of investors including Accel, Chiratae, Kalaari, and Oaktree which value the company at INR 3,700 crore.

Pradeep Singh
Pradeep Singh

Former interim CTO at LAFFAZ. A full-stack developer, possessing 6+ years of experience in working closely with tech startups in India and UAE.

Connect: LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *